Astrazeneca (AZN) Cash from Operations (2009 - 2019)

Astrazeneca (AZN) posted quarterly Cash from Operations of 1979000000.0 for Q2 2019, up 611.37% quarter-over-quarter from 387000000.0 in Q1 2019.

Astrazeneca (AZN) Cash from Operations (2009 - 2019) Analysis & Trends

Astrazeneca's Cash from Operations history runs 7 years deep, the most recent figure standing at 1979000000.0 for Q2 2019.

In Q2 2019, Cash from Operations changed N/A year-over-year to 1979000000.0; the TTM figure through Jun 2019 stood at 2611464966.33 (changed N/A YoY), while the FY2025 annual figure was 18736000000.0, up 17.66% from the prior year.
Cash from Operations for Q2 2019 stood at 1979000000.0, up from 387000000.0 in the prior quarter.
The five-year high for Cash from Operations was 1979000000.0 in Q2 2019, with the low at 387000000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	8.62 Bn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	3.44 Bn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	5.37 Bn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	5.88 Bn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	4.00 Bn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	3.57 Bn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	835.00 Mn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	2.55 Bn

Download Data